CoChat

Targeting HDACs: A Promising Therapy for Alzheimer's Disease

Open access
Xu, Ke, Dai, Xue-Ling, Huang, Han-Chang, Jiang, Zhao-Feng · 2011 · Oxidative Medicine and Cellular Longevity
Cited by 202

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Epigenetic modifications like DNA methylation and histone acetylation play an important role in a wide range of brain disorders. Histone deacetylases (HDACs) regulate the homeostasis of histone acetylation. Histone deacetylase inhibitors, which initially were used as anticancer drugs, are recently suggested to act as neuroprotectors by enhancing synaptic plasticity and learning and memory in a wide range of neurodegenerative and psychiatric disorders, such as Alzheimer's disease (AD) and Parkinson's disease (PD). To reveal the physiological roles of HDACs may provide us with a new perspective to understand the mechanism of AD and to develop selective HDAC inhibitors. This paper focuses on the recent research progresses of HDAC proteins and their inhibitors on the roles of the treatment for AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2011/143269

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 202

Metadata

Authors
Xu, K., Dai, X.-L., Huang, H.-C., & Jiang, Z.-F.
Venue
Oxidative Medicine and Cellular Longevity
Publisher
Wiley
Published
2011
Volume
2011
Pages
1-5
ISSN
  • 1942-0994 (ISSN-L)
  • 1942-0900
OpenAlex
W2112808742
Cited by
202
References
18
FWCI
3.06
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting HDACs: A Promising Therapy for Alzheimer's Disease. https://app.cochat.ai/papers/10.1155/2011/143269
The paper
Xu, K., Dai, X.-L., Huang, H.-C., & Jiang, Z.-F. (2011). Targeting HDACs: A Promising Therapy for Alzheimer's Disease. Oxidative Medicine and Cellular Longevity. https://doi.org/10.1155/2011/143269

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.